Aufman Associates Inc Abb Vie Inc. Transaction History

Aufman Associates Inc

$155 Million
Q3 2024

A detailed history of Aufman Associates Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Aufman Associates Inc holds 3,331 shares of ABBV stock, worth $584,856. This represents 0.42% of its overall portfolio holdings.

Number of Shares

3,331

Previous 2,461 35.35%

Holding current value

$584,856

Previous $422,000 55.69%

% of portfolio

0.42%

Previous 0.3%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$163.84 - $199.33 $142,540 - $173,417	870 Added 35.35%	3,331 $657,000
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $137 - $154	1 Added 0.04%	2,461 $381,000
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $7,347 - $8,505	-55 Reduced 2.19%	2,460 $366,000
Q2 2023 Aug 11, 2023	SELL	$132.51 - $164.9 $20,274 - $25,229	-153 Reduced 5.73%	2,515 $338,000
Q1 2023 May 10, 2023	SELL	$144.61 - $166.54 $9,688 - $11,158	-67 Reduced 2.45%	2,668 $425,000
Q4 2022 Feb 08, 2023	SELL	$138.31 - $165.87 $2,766 - $3,317	-20 Reduced 0.73%	2,735 $442,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $19,997 - $22,935	-149 Reduced 5.13%	2,755 $370,000
Q2 2022 Aug 10, 2022	SELL	$137.62 - $174.96 $30,964 - $39,366	-225 Reduced 7.19%	2,904 $445,000
Q1 2022 May 13, 2022	SELL	$131.98 - $163.75 $14,517 - $18,012	-110 Reduced 3.4%	3,129 $507,000
Q4 2021 Feb 09, 2022	BUY	$107.43 - $135.93 $2,256 - $2,854	21 Added 0.65%	3,239 $439,000
Q2 2021 Aug 11, 2021	BUY	$105.21 - $117.21 $12,414 - $13,830	118 Added 3.81%	3,218 $362,000
Q3 2020 Nov 13, 2020	SELL	$85.91 - $100.83 $8,848 - $10,385	-103 Reduced 3.22%	3,100 $272,000
Q4 2019 Feb 06, 2020	BUY	$72.13 - $90.25 $231,032 - $289,070	3,203 New	3,203 $284,000

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $310B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aufman Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Aufman Associates Inc with notifications on news.

Account

Aufman Associates Inc Abb Vie Inc. Transaction History